BackNewron Pharmaceuticals S.p.A. Overview

Newron Pharmaceuticals S.p.A. Other Current Liabilities

Latest other current liabilities for NWPHF: $7.6M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$7.63M
↑ 49.70% YoYΔ $2.53M vs prior year quarter

Peer trimmed avg / median

Loading

Newron Pharmaceuticals S.p.A. Other Current Liabilities History

Loading

Newron Pharmaceuticals S.p.A. vs. peers: Other Current Liabilities Comparison

Loading

Newron Pharmaceuticals S.p.A. Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Newron Pharmaceuticals S.p.A. (NWPHF) FAQ

Newron Pharmaceuticals S.p.A. posts a other current liabilities of $7.6M as of June 2026. That compares with $5.1M in the prior-year period — up 49.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Newron Pharmaceuticals S.p.A.'s other current liabilities was $5.1M. The latest reading is $7.6M — a 49.7% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Newron Pharmaceuticals S.p.A.'s financial statement story. At $7.6M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NWPHF's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Newron Pharmaceuticals S.p.A.'s other metric pages and overview cover the third.

Judging Newron Pharmaceuticals S.p.A. against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $7.6M here, then scan peer and history charts to see if the gap is persistent.

Questions & Answers